Thursday, May 23, 2013

Look Who’s Attending the Gross-to-Net Forum

The Gross-to-net Accounting Forum will be here before you know it—seats are filling up rapidly!

Since its introduction, the buzz for this event has been building more and more each week, with positive feedback from our growing attendee list. Join us and the confirmed attendees from the following companies to ensure you do not miss out on learning the newest developments in the GTN process.

Acorda Therapeutics*Actient Pharmaceuticals*Afaxys, Inc*Alliance Life Sciences Consulting*AMAG Pharmaceuticals Inc*Amgen*Amneal Pharmaceuticals*APP Pharmaceuticals, LLC*ARIAD Pharmaceuticals Incorporated*Astellas Pharma US*AstraZeneca*Bayer HealthCare Pharmaceuticals*Boehringer Ingelheim Pharmaceuticals*BPI Technologies*Covidien*Daiichi Sankyo*DDN*Eli Lilly & Co*Exelixis*Faulkner Mackie & Cochran PC*Forest Laboratories Inc*Forest Pharmaceuticals Inc *GlaxoSmithKline*Grifols*IMS HEALTH*Incyte*Jazz Pharmaceuticals*King & Spalding LLP*LEO Pharma Inc*Millennium: The Takeda Oncology Company*Mylan*Neos Therapeutics*Optimer Pharma*PPS - Professional Provider Services Inc.*Purdue Pharma*Revitas*Salix Pharmaceuticals*Sanofi-Aventis*Shionogi Inc.*Sunovion Pharmaceuticals*Vertex Pharmaceuticals*Vertical / Trigen*Warner Chilcott

Any many more! To view our full program, download our brochure.

As a reader of the healthcare insights blog, you get a 15% discount off the standard rate when using code XP1811BLOG to register. If you have any questions about the agenda or event, please contact Kate Devery at or visit our webpage.

We look forward to seeing you this June!

The GTN Team

Visit our homepage
Follow us on Twitter

No comments: